EYEN
$3.21
Eyenovia
$.01
.31%
EYEN
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.15)
Revenue:  $4.00 Mil
Wednesday
Nov 11
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, August 12, 2020

What do you expect when EYEN reports earnings?
Beat
Meet
Miss

Where is EYEN's stock price going from here?
Up
Flat
Down
Stock chart of EYEN
Analysts
Summary of analysts' recommendations for EYEN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc. is based in New York.